• 国家药监局综合司 国家卫生健康委办公厅
  • 国家药监局综合司 国家卫生健康委办公厅

Study on the Influencing Factors of Selection and Price Decline in the Centralised Volume-Based Purchase of Chinese Patent Medicine --Taking Hubei Province as an example

Corresponding author: cuidan, alyssazz@126.com
DOI: 10.12201/bmr.202504.00012
Statement: This article is a preprint and has not been peer-reviewed. It reports new research that has yet to be evaluated and so should not be used to guide clinical practice.
  •  

    Abstract: Objective: Analyse the factors affecting whether the first two batches of centralized volume-based procurement of Chinese Patent Medicine were selected, the price difference and the rate of reduction, so as to provide a basis for improving the policy of centralized volume-based procurement of Chinese Patent Medicine.Methods: The first two batches of centralised volume-based procurement of Chinese Patent Medicine were selected for the study. Logistic regression was used to analyse the influencing factors of whether the selection was won or not. Multiple linear regression was used to analyse the influencing factors of price difference/reduction after being selected. Results:Proprietary Chinese medicines with a high degree of acceptance by medical institutions and belonging to the category of essential medicines have a higher probability of being selected. The probability of selected products in the first batch of centralised purchase is greater for enterprises with a market share of more than 50%. In the first batch of centralized volume-based procurement of Chinese Patent Medicine, the price difference of injections and medicines belonging to the catalogue of essential medicines is greater. Price reductions were greater for those with low market share, low recognition by medical institutions, and a large number of enterprises in the A-competition unit and the same competition unit. In the second batch of centralised volume-based procurement of Chinese Patent Medicine, the price difference is greater for injections, and those with qualifications for the production of Chinese herbal medicines. the price reduction is greater in the B competitive unit.Conclusion: The centralized volume-based procurement of Chinese Patent Medicine has been both ‘quality-assured’ and ‘price-reduced’. The centralized volume-based procurement of Chinese Patent Medicine has been gradually improved, and the tilt towards large enterprises has been reduced, so that the centralized volume-based procurement of Chinese Patent Medicine can achieve a ‘bottom price’. However, it is still necessary to start from the quality of identification, fair competition, and so on, and the centralized volume-based procurement of Chinese Patent Medicine fully linked to promote the centralized purchase of Traditional Chinese Medicine Decoction Pieces to a stable and far-reaching.

    Key words: Centralised Volume-Based Procurement of Chinese Patent Medicine; Price Reduction; Influencing Factors; Regression Analysis

    Submit time: 7 April 2025

    Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
  • 图表

  • Sun Yan, Zhu Zheng, Yang Li. Influencing factors analysis on price reduction in national volume-based drug procurement.. 2022. doi: 10.12201/bmr.202203.00008

    HAN Meng, WANG Shi-jia, HU Hao-yu, ZHAO Yan-jiao, CHEN Yong-fa. Comparative Study on Grouping Rules in Centralized Volume-based Procurement of Chinese Patent Medicine. 2023. doi: 10.12201/bmr.202312.00008

    WangBiao, Zhang Tiantian, Tang Xiaoyu, Jia Yun, Luo Li. A study of price reduction sustainability in national volume-based drug procurement. 2023. doi: 10.12201/bmr.202305.00008

    YANG Ying, LIU Yu-xin, MAO Jing, MAO Zong-fu. The impact of volume-based procurement policy on the pharmaceutical industry: A systematic review based on the SCP paradigm. 2024. doi: 10.12201/bmr.202401.00003

    Zhao Hanqing. Knowledge reasoning and intelligent recommendation based on knowledge map of Chinese patent medicine. 2024. doi: 10.12201/bmr.202404.00018

    LIU MINGZHU, LU YUN. Research on the Implementation Effect of Expiration of National Pharmaceutical Centralized Volume-based Procurement Based on Intermittent Time Series: A Case Study of Hebei Province. 2023. doi: 10.12201/bmr.202306.00007

    wangennan, zhuminglai. Evolutionary Game Research on Price Negotiation of Patent Medicine Medical Insurance in China. 2023. doi: 10.12201/bmr.202303.00032

    lvshuzhen. Study on the Factors Influencing Patients Willingness to Use Chinese Medicine Delivery Service Based on Hospital WeChat Public Platform. 2022. doi: 10.12201/bmr.202209.00010

    Guo shasha, SHEN-Liyan, WANG Quan, YAO Lu, ZHEN Xue-mei, SUN Qiang. Research on influencing factors of irrational use of antibiotics in village doctors based on qualitative comparative analysis of fuzzy sets. 2021. doi: 10.12201/bmr.202106.00018

    WangBiao, Zhang Tiantian, Tang Xiaoyu, Jia Yun, Luo Li. Research on the price difference and regional distribution of selected drugs in Chinas centralized procurement. 2023. doi: 10.12201/bmr.202306.00008

  • ID Submit time Number Download
    1 2025-02-17

    bmr.202504.00012V1

    Download
  • Public  Anonymous  To author only

Get Citation

anshuhan, xiangjing, caimengna, cuidan. Study on the Influencing Factors of Selection and Price Decline in the Centralised Volume-Based Purchase of Chinese Patent Medicine --Taking Hubei Province as an example. 2025. biomedRxiv.202504.00012

Article Metrics

  • Read: 47
  • Download: 1
  • Comment: 0

Email This Article

User name:
Email:*请输入正确邮箱
Code:*验证码错误